Founded in 2015 and based in Santa Clara, California, OmniTier is a technology company dedicated to solving complex computation problems in genetics and precision analysis. The company's core mission is to deliver affordable precision medicine solutions that enhance healthcare outcomes. OmniTier offers end-to-end genomic analysis through standalone appliances that are fast, accurate, secure, low-cost, and scalable, empowering researchers and clinicians to implement custom methodologies.
OmniTier has made significant strides in the field of genomics, with notable affiliations including collaborations with institutions like NCCHD in Japan, which demonstrated improved diagnostic rates for rare diseases using OmniTier’s technology. The company has garnered attention for its innovative approach to genomic analysis, making a substantial impact on precision medicine and healthcare research.
